ASSESSMENT OF KNOWLEDGE–ATTITUDE–PRACTICE TOWARD MEDICATION DISPENSE FOR GASTROESOPHAGEAL REFLUX DISEASE OF PHARMACISTS IN HO CHI MINH CITY

Hoàng Vân Nga Nguyễn , Thị Quỳnh Nga Nguyễn

Main Article Content

Abstract

Objective: To evaluate the knowledge–attitude–practice of pharmacists toward medication dispenses for treating gastroesophageal reflux disease (GERD) in community pharmacies in Ho Chi Minh City (HCMC). Methods: A cross–sectional descriptive study using simulated patient method on 413 in HCMC from December 2022 to May 2023. Results: The majority of pharmacists correctly answered the questions related to general knowledge about GERD and medication abuse. Knowledge of medication use principles, PPI resistance and medicine retail regulations achieved average scores. Most pharmacists understood the current situation of PPI abuse and encouraged customers to seek physicians for prescription. However, most pharmacists did not exploit patient’s medical history and advise on drug use. Some factors related to pharmacist's knowledge, attitude and practice included seniority with knowledge; number of working hours with their attitude; gender, professional qualifications, type of pharmacy with their practice. Conclusion: In general, the knowledge and attitude scores of pharmacists were from average to good while their practice scores wể still limited. Periodical training for pharmacists at community pharmacies can enhance knowledge, attitude and practice toward medication dispense for GERD treatment.

Article Details

References

1. Goh K, hepatology CWG&, 2006. Gastroesophageal reflux disease: an emerging disease in Asia. ncbi.nlm.nih.gov. https://www. ncbi.nlm.nih.gov/pmc/articles/PMC5335627/
2. Maret-Ouda J, Markar SR, Lagergren J. Gastroesophageal Reflux Disease: A Review. JAMA. 2020;324(24):2536-2547. doi:10.1001/JAMA.2020.21360
3. Rutter P. Community pharmacy: symptoms, diagnosis and treatment. https://books.google. com/books?hl=vi&lr=&id=y5XnDwAAQBAJ&oi=fnd&pg=PP1&dq=Paul+Rutter+-+Community+ Pharmacy+Symptoms,+Diagnosis+and+Treatment-Elsevier+(2020)&ots=igO_wtwaab&sig=k7WMx l0Ip5Gi5JL9trh4KF7NLcc
4. The Montreal Definition and Classification of Gastroesophage... : Official journal of the American College of Gastroenterology | ACG. https://journals.lww.com/ajg/Abstract/ 2006/08000/The_Montreal_Definition_and_Classification_of.33.aspx
5. El-Serag H, Sweet S, Winchester C, Gut JD, 2014. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. gut.bmj.com. https://gut.bmj.com/content/63/6/ 871.short
6. Quach DT, T Pham QT, T Tran TL, et al. Clinical characteristics and risk factors of gastroesophageal reflux disease in Vietnamese patients with upper gastrointestinal symptoms undergoing. Wiley Online Library. 2021;5(5):580-584. doi:10.1002/jgh3.12536
7. Boura F, Al-Tabakha MM, Hassan N, Darwich M. Community pharmacists’ response to complaints of gastroesophageal reflux: A simulated patient study in the Northern United Arab Emirates. PLoS One. 2023;18(1 January). doi:10.1371/JOURNAL.PONE.0279922
8. Luo H, Fan Q, Bian T, et al. Awareness, attitude and behavior regarding proton pump inhibitor among medical staff in the Southwest of China. BMC Health Serv Res. 2019;19(1):1-9. doi:10.1186/S12913-019-4725-6/TABLES/7